September 13-16, 2021

International Conference on the Molecular Biology and Pathogenesis of the Clostridia


Welcome

While we would have loved to have met fellow investigators in the beautiful setting of Banff, Canada this fall, ClostPath 12, will be held virtually from September 13-16, 2021 (September 14-17, 2021 for Asia/Australia).

For over 20 years, the biennial International Conference on the Molecular Biology & Pathogenesis of the Clostridia (ClostPath) has been an important venue for bringing scientists and clinicians together to share and discuss the latest research on the molecular biology of the clostridia and their role in health and disease.

Conference Goals

As with previous ClostPath meetings, ClostPath 12 will cover the latest developments in our understanding of how clostridial pathogens cause disease. The Scientific Program of ClostPath 12 will include keynote lectures by internationally recognized leaders in the field of clostridial research and will also highlight work from early-stage investigators. The conference aims to present the most recent and exciting work in the field from invited speakers as well as from contributors whose submitted abstracts have been selected by our International Scientific Steering Committee. In addition to scientific excellence, the committee has a longstanding commitment to ensuring a diverse panel of speakers in terms of gender, geography, race/ethnicity, and scientific interest. Interactive, cutting-edge poster sessions will provide attendees with the opportunity to share their work with a broad audience, generate new ideas, and foster cross-disciplinary conversations. Attendees have been encouraged to submit abstracts on their most recent or as yet unpublished work.

A major objective of ClostPath is to provide a forum for trainees (students and postdoctoral fellows) to share their work, discuss their data with leading scientists, and train and inspire the next generation of clostridial researchers. Events specifically for Young Scientists will be integrated into the conference. The conference will begin with a Young Scientist Pre-Meeting and conclude with a Career Panel Discussion. ClostPath 12 will also be holding social hours at the end of the sessions on Monday, September 13 and Wednesday, September 16. Please see the Program tab for more details.

To maximize engagement with poster presenters, ClostPath 12 will be holding both live and asynchronous poster viewing sessions using the Symposium One platform (https://symposium.foragerone.com/clostpath-12). This platform will allow ClostPath 12 attendees to comment on poster flash talks and ask questions of the poster presenters both synchrnously and asynchronously.

We very much look forward to seeing you in a virtual format at ClostPath 12.

Yours sincerely,

Aimee Shen, Ph.D.

Borden Lacy, Ph.D.

Clostpath 12 Conference Co-Chairs

On behalf of the Organizing Committee

Logo credit: Rita Tamayo, Ph.D.

Gold Sponsorship

  • NIAID

Silver Sponsorship

  • BWF_logo.1611633231.png
  • Rebiotix_Extra Small Logo.1615305833.jpg
  • Merck
  • BioVector

Bronze Sponsorship

  • TECHLAB logo_tagline_2021.1611109435.jpg
  • Summit Therapeutics
  • Ferring

Sponsored Speakership

  • 151125160500_9327_Toxins-01.1611025210.png

Institutional Sponsors

  • Tufts University School of Medicine
  • VI4

Invited Speakers

Keynote Lecturer

Dr. Julian Rood, Ph.D. Monash University, Australia.

State-of-the-Art Lecturers

Dr. Eric Skaar, Ph.D. Vanderbilt University Medical Center, USA.

Dr. Rita Tamayo, Ph.D. University of North Carolina, USA. (Tomru Shimzu Lecture)

Dr. Roman Melnyk, Ph.D. University of Toronto, Sick Kids Hospital Research Institute, Canada. (Toxins Sponsored Lecture)

Invited Lecturers

Dr. Lynn Bry, M.D./Ph.D. Brigham and Women’s Hospital, USA.

Dr. Brigitte Dorner, Ph.D. Robert Koch Institut, Germany.

Dr. Simon Hirota, Ph.D. University of Calgary, Canada

Dr. Julian Hurdle, Ph.D. Texas A&M University, USA.

Dr. Nobuhiko Kamada, Ph.D. University of Michigan, USA.

Dr. Daniel Knight, Ph.D. Murdoch University, Australia

Dr. Thomas Louie, M.D. University of Calgary, Canada.

Dr. Isabelle Martin-Verstraete, Ph.D. Pasteur Institut and Université Paris Diderot, France.

Dr. Shonna McBride, Ph.D. Emory University School of Medicine, USA.

Dr. Sabine Pellett, Ph.D. University of Wisconsin, Madison, USA.

Dr. Wiep Klaas Smits, Ph.D. Leiden University Medical Center. The Netherlands.

Dr. Francisco Uzal, D.V.M./Ph.D. University of California, Davis, USA.

    Location

    Banff Conference Centre

    107, Tunnel Mountain Drive Banff, Alberta Canada

    Registration period

    April 28, 2021 - 00:00 until September 8, 2021 - 14:00

    Submission period

    March 11, 2020 - 00:00 until August 4, 2021 - 06:00

    Contact us

    If you have any questions, please contact clostpath2021@gmail.com .

    Powered by